ID   YBLi004-A
AC   CVCL_D0Q8
SY   YBL/SH/2018/0062
DR   BioSamples; SAMEA112910433
DR   hPSCreg; YBLi004-A
DR   Wikidata; Q123033949
RX   PubMed=38547666;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38547666
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
RX   PubMed=38547666; DOI=10.1016/j.scr.2024.103402;
RA   Sarkar J., Dhepe S., Shivalkar A., Kuhikar R., More S., Konala V.B.R.,
RA   Bhanushali P., Khanna A.;
RT   "Generation of human-induced pluripotent stem cell line from PBMC of
RT   healthy donor using integration-free Sendai virus technology.";
RL   Stem Cell Res. 77:103402-103402(2024).
//